Clinical Impact of Nasal Obstructive Syndrome and Its Current Management Strategies.

Nasal obstruction syndrome (NOS) is inherently complex due to the combination of nasal anatomy and physiology and pathophysiologic processes that together affect airflow, filtering, smell, and the general health of the respiratory system. The nasopharynx consists of different structures together: the septum, turbinates, and nasal valves that together perform the jobs associated with the nasal polyp, which is to regulate air conditioning and mucociliary clearance. Changes that can be recognized in the septum, turbinates, and nasal valve will individually and/or collectively affect the potential for airway obstruction. However, obstructions may not occur as a function of anatomy; they may occur via anatomical functional restrictions, as is believed to be the case with breathing-facilitating trigeminal nerve dysfunction, evidenced by the subjective sensations of nasal obstruction while no anterior nasal obstruction is observed. In addition to anatomical changes such as turbinate hypertrophy, outpt septal deviation, and/or nasal valve collapse, there are also chronic inflammatory disease states such as rhinosinusitis, allergic and non-allergic rhinitis, and nasal polyposis that will develop to produce nasal obstructions via mucosal edema and structural room through tissue remodeling. The clinical consequence of NOS is nasal airway congestion, hyposmia, and compensatory mouth breathing, with the latter two activities causing harm to sensory deficits such as taste, sleep quality, and cognitive functioning, and impedance in health-related quality of life. Commonly utilized diagnostic procedures include nasal endoscopy, CT, and testing for the effects of nasal obstruction (e.g., the Nasal Obstruction Symptom Evaluation (NOSE) scale, Sino-Nasal Outcome Test-22 (SNOT-22), and Visual Analog Scale (VAS)), which are specific to confirm the effect of nasal obstruction. Radiological and nasal endoscopic findings focused on anatomical distortions and specific patterns of obstructive nasal difficulty, particularly in chronic, difficult-to-treat rhinosinusitis and nasal valve obstruction. Management plans unite both pharmacologic options, such as antihistamines, corticosteroids, and immunotherapies, with surgical procedures, which can include septoplasty, turbinate reduction, nasal valve reconstruction, and functional endoscopic sinus surgery (FESS). Treatment will depend on the patient's specific medical and social history, which is especially critical for children, older-age patients, and patients with comorbid respiratory problems such as asthma or obstructive sleep apnea (OSA). For children, the typical catalyst for nasal obstruction appears to be adenoid hypertrophy, whereas older patients may differ in their nasal microbiota. Management is a multidisciplinary team effort, engaging otolaryngology, allergy, and pulmonology specialists to treat this multifaceted condition.